Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Transgene
100%
Iduronidase
100%
Promoter Region
100%
Retrovirus Vector
100%
Mucopolysaccharidosis
100%
Hurler Syndrome
100%
Hematopoietic Cell
100%
Peripheral Blood Lymphocyte
50%
Fibroblast
50%
Selectable Marker
25%
Gene Expression
25%
down Regulation
25%
CD34
25%
Internal Ribosome Entry Site
25%
Drug Resistance
25%
Keyphrases
Design Study
100%
Photosystem II
100%
Vector Design
100%
Hematopoietic Stem Cell Gene Therapy
100%
Retroviral Vector
100%
α-L-iduronidase
66%
Peripheral Blood Lymphocytes
33%
Transgene Expression
33%
Bicistronic Vector
33%
Gene Expression
16%
Complementary DNA (cDNA)
16%
Hematopoietic Cells
16%
Selective Pressure
16%
CD34+
16%
Decreased Expression
16%
Selectable Marker
16%
Patient Fibroblasts
16%
Therapeutic Gene
16%
Specific Promoter
16%
Dual Promoter
16%
Fibroblast Cell Line
16%
Gene Transfer Systems
16%
Internal Ribosome Entry Site
16%
Co-selection
16%
K Promoter
16%
Drug Resistance Gene
16%
Murine Fibroblasts
16%
Neuroscience
Promoter Region
100%
Retrovirus Vector
100%
Levo Iduronidase
100%
Transgene
100%
Hurler Syndrome
100%
Hematopoietic Cell
100%
Lymphocyte
50%
Fibroblast
50%
Complementary DNA
25%
Gene Delivery
25%
CD34
25%
Internal Ribosome Entry Site
25%
Gene Expression
25%
Cell Line
25%
Gene Transfer
25%
Drug Resistance
25%
Immunology and Microbiology
Promoter Region
100%
Retrovirus Vector
100%
Hematopoietic Cell
100%
Transgene
100%
Peripheral Blood Lymphocyte
50%
Drug Resistance
25%
Gene Expression
25%
down Regulation
25%
CD34
25%
Gene Transfer
25%
Fibroblast Cell Line
25%
Internal Ribosome Entry Site
25%
Fibroblast
25%